This year, the Sceales Antrobus Cancer Research Trust is bringing the renowned Dr Krishna B Clough to our African soil. He is a world leader in Oncoplastic Breast Surgery, having been instrumental in its creation and subsequently developing the classification of oncoplastic surgery techniques which is considered the reference paper in this field.
He spent more than 15 years in the French public system, and was the Chief of Surgery at the Institut Curie in 1996 at the age of 38. In 2004, he left the Institut Curie to create the Paris Breast Centre, France’s first private Breast Centre, which now hosts 7 breast surgeons and a multidisciplinary team of 20 physicians dedicated to the care of women with breast cancer, in addition to benign breast disease, and cosmetic breast surgery.
Dr Clough is a dually qualified surgical oncologist and a plastic surgeon and has focused on offering patients the benefits of a multidisciplinary approach whilst limiting the side effects of each of the treatments applied.
His clinical research aims at developing a global surgical expertise for breast surgery, from non-palpable breast cancer to all types of breast reconstruction, including all possible surgical procedures for diagnosis, treatment and reconstructive surgery of the breast.
With more than 160 articles in international peer reviewed journals, his clinical research continues in the busiest private practice in France. He has been invited to present at all major international conferences and will be joining us at this year’s BIGOSA Scientific Meeting. Don’t miss your opportunity to learn more directly from this remarkable leader in person.
Dr Prashni Govender matriculated in 1999 and then proceeded to join University of Kwa-Zulu Natal where she completed her undergraduate medical training(MBchB) in 2005, graduating summa cum Laude.
From here she joined the department of anatomical pathology at Inkosi Albert Luthuli hospital to begin post graduate training in 2007. She completed FCpath (anatomical pathology) in 2012.
Her work continued at the NHLS as a specialist consultant involved in service delivery, registrar training and undergraduate lectures. In 2015 she joined Lancet Laboratories as a specialist histopathologist. She is actively involved in histopathology as well as frozen section work.
Dr. Johan van Heerden is based at Cintocare Hospital, Menlyn Maine, Pretoria. He is part of the Multi-Disciplinary Breast Cancer Team at Life Groenkloof Hospital.
He recently passed the Certificate of Competence in Breast Cancer with the European School of Oncology. He regularly presents at congresses, Journal Clubs and CPD events.
With a keen interest in Breast Reconstruction, he has been in Private Practice for 15 years. Dr van Heerden strongly believes that all women with breast cancer should at least be offered the different options of reconstruction before surgery, for them to make an informed choice.
He qualified as a Fellow of the College of Plastic Surgeons of South Africa and completed his MMed in 2010. He published two articles as Registrar in Plastic Surgery – notably, one being a comparative study of suturing materials and the other one on Biofilm formation on silicone breast implant material.